PrecisionLife’s Post COVID DNA Wellness Report Places World-Leading Long COVID Genetic Research Directly in Consumers’ Hands

New report provides personalized wellness insights for the 18 million US adults currently living with post COVID symptoms

On September 29, 2026, PrecisionLife, an AI-led precision medicine company focused on complex chronic diseases, launched the “Post COVID DNA Wellness Report,” translating more than five years of leading long COVID research into personalized genetic information that consumers can access directly.

The report enables individuals to explore their genetic profile, see how selected patterns in their DNA compare with those observed in research populations of people known to have long COVID, and be more informed about their health and general well-being. It is available directly from PrecisionLife in the US.

Post COVID conditions are a major public health burden. Latest figures indicate that 5.3% of U.S. adults – over 18 million people – are currently affected by long COVID[1], with estimates suggesting that the condition may be linked to $170 billion in lost U.S. earnings each year and an annual global economic burden approaching $1 trillion[2]. The scale and complexity of the condition, which causes diverse and debilitating symptoms, highlights the need for reliable, research-based information to be made more accessible.

The “Post COVID DNA Wellness Report” provides an at-home cheek swab kit for customers to collect a DNA sample. Following lab analysis, the personalized report presents results across the genetic patterns associated with six key biological mechanisms and identifies the genes contributing to each result, providing a detailed view of an individual’s genetic profile in the context of long COVID research.

The report draws on PrecisionLife’s world-leading research into both ME/CFS and long COVID, identifying the first reproducible disease mechanisms and associated patient subgroups for both conditions. This work uncovered over 180 genes linked to long COVID and the first clear genetic overlap with ME/CFS[3],[4],[3]. The research was published in a series of open access, peer-reviewed papers in the Journal of Translational Medicine and presented at international ME/CFS and long COVID Conferences and is the most detailed genetic analysis of long COVID to date.

The “Post COVID DNA Wellness Report” was developed in collaboration with international patient advocacy groups, specialist clinicians, and people with lived experience, representing over 100 million individuals living with long COVID and Post Acute Infection Syndromes (PAIS) globally. It is accompanied by a comprehensive educational guide summarizing published long COVID research, commonly reported symptoms, and well-being approaches that have been discussed in the scientific literature.

“Long COVID has profoundly disrupted the lives of tens of millions of people, who often have little support. This report puts our peer-reviewed research directly into their hands, helping them understand their own individual genetic profile in the context of mechanisms known to impact on the condition from our research studies. We want them to be able to have more informed conversations that could improve their general well-being,” said Steve Gardner, PhD, Founder and CEO of PrecisionLife. “Launching this report also marks a critical milestone for PrecisionLife – it’s the first time our research has moved from the lab into an accessible consumer product, reflecting our broader mission to turn deep genetic research into real, actionable insights for the 5 billion patients affected by a wide range of complex chronic diseases globally.”

For more information, visit www.precisionlife.com/postcovid.

[News release]